IGKV1D-22 and COVID-19: Mellett et al. [50] suggested that S100A8/A9 could serve as a potential biomarker for COVID-19, as increased serum levels of S100A8/A9 are linked to severe COVID-19 cases and can differentiate between mild and severe disease.